Valion Bio announces 1-for-25 reverse stock split to regain Nasdaq compliance

Valion Bio, Inc.

1-for-25 reverse stock split effective Aug 31, 2026; trading symbol VBIO unchanged, new CUSIP 918942202.
Split aims to regain Nasdaq $1.00 minimum bid price compliance; prior notice from Nasdaq on Mar 19, 2026, deadline Sep 15, 2026.
Stockholders approved split at special meeting Aug 14, 2026; fractional shares rounded up, no cash paid.
Proportionate adjustments to preferred stock, warrants, options, and 2021 equity incentive plan shares.
Transfer agent Odyssey acts as exchange agent; no action needed for book-entry or broker-held shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.